About: The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Transcriptomic screens in breast cancer cell lines have identified a protein named anterior gradient-2 (AGR2) as a potentially novel oncogene overexpressed in estrogen receptor (ER) positive tumours. As targeting the ER is responsible for major improvements in cure rates and prevention of breast cancers, we have evaluated the prooncogenic function of AGR2 in anti-hormone therapeutic responses. We show that AGR2 expression promotes cancer cell survival in clonogenic assays and increases cell proliferation and viability in a range of cancer cell lines. Chromatin immunoprecipitation and reporter assays indicate that AGR2 is transcriptionally activated by estrogen through ER alpha. However, we also found that AGR2 expression is elevated rather than inhibited in response to tamoxifen, thus identifying a novel mechanism to account for an agonistic effect of the drug on a specific pro-oncogenic pathway.
  • Transcriptomic screens in breast cancer cell lines have identified a protein named anterior gradient-2 (AGR2) as a potentially novel oncogene overexpressed in estrogen receptor (ER) positive tumours. As targeting the ER is responsible for major improvements in cure rates and prevention of breast cancers, we have evaluated the prooncogenic function of AGR2 in anti-hormone therapeutic responses. We show that AGR2 expression promotes cancer cell survival in clonogenic assays and increases cell proliferation and viability in a range of cancer cell lines. Chromatin immunoprecipitation and reporter assays indicate that AGR2 is transcriptionally activated by estrogen through ER alpha. However, we also found that AGR2 expression is elevated rather than inhibited in response to tamoxifen, thus identifying a novel mechanism to account for an agonistic effect of the drug on a specific pro-oncogenic pathway. (en)
Title
  • The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers
  • The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers (en)
skos:prefLabel
  • The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers
  • The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers (en)
skos:notation
  • RIV/00216224:14110/10:00051809!RIV12-MSM-14110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, P(GAP301/10/1615), P(NS9812), Z(MZ0MOU2005)
http://linked.open...iv/cisloPeriodika
  • 34
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 282870
http://linked.open...ai/riv/idVysledku
  • RIV/00216224:14110/10:00051809
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • AGR2; tamoxifen; letrozole; estrogen receptor; breast cancer (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [75F17E7F2E7E]
http://linked.open...i/riv/nazevZdroje
  • Oncogene
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 29
http://linked.open...iv/tvurceVysledku
  • Hrstka, Roman
  • Petráková, Katarína
  • Vojtěšek, Bořivoj
  • Nenutil, Rudolf
  • Dixon, M.
  • Fourtouna, A.
  • Hupp, T.
  • Langdon, S.
  • Larionov, A.
  • Maslon, M.
  • Muller, P.
  • Murray, E.
  • Naughton, C.
http://linked.open...ain/vavai/riv/wos
  • 000281326400009
http://linked.open...n/vavai/riv/zamer
issn
  • 0950-9232
number of pages
http://bibframe.org/vocab/doi
  • 10.1038/onc.2010.228
http://localhost/t...ganizacniJednotka
  • 14110
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software